Takeda sells generics portfolio to Stada for $660m
06-11-2019
Jury orders Takeda subsidiary to pay Bayer $155 million
06-02-2019
Jonathan Weiss / Shutterstock.com
A Takeda subsidiary cannot overturn a $155 million jury verdict that it infringed one of Bayer’s patents, a district court has ruled.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Takeda, Baxalta, Bayer, hemophilia, patent infringement, US District Court for the District of Delaware
